Suzetrigine-D3 | CAS 2649467-62-7 - Request Quote
Suzetrigine-D3
| SZ CAT No: | SZ-S123D02 |
| CAS No | 2649467-62-7 |
| Mol.F. | C21H17D3F5N3O4 |
| Mol.Wt. |
476.4 |
| Inv. Status |
Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Suzetrigine-D3 is chemically 4-((2R,3S,4S,5R)-3-(3,4-difluoro-2-(methoxy-d3)phenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-carboxamido)picolinamide. Suzetrigine-D3 is supplied with detailed characterization data compliant with regulatory guideline. Suzetrigine-D3 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Suzetrigine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 2649467-62-7
Purchase 2649467-62-7
Order 2649467-62-7
Enquire 2649467-62-7
price of 2649467-62-7
2649467-62-7 Supplier
2649467-62-7 Manufacturer
2649467-62-7 Exporter
buy high quality Suzetrigine-D3
Purchase Suzetrigine-D3
Suzetrigine-D3 suppliers
Suzetrigine-D3 manufacturers
Suzetrigine-D3 price
Order Suzetrigine-D3
Enquire Suzetrigine-D3
Suzetrigine-D3 cost
Suzetrigine-D3 Supplier
Suzetrigine-D3 Distributor
Suzetrigine-D3 for Method Validation
Suzetrigine Reference Standard
Suzetrigine-D3 for ANDA Filing
Suzetrigine-D3 for Forced Degradation Studies
Suzetrigine-D3 Identification Standards
Suzetrigine-D3 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.